Stephen Hauser From University of California San Francisco: Ocrelizumab Provides Potential Answer to Difficult Treatment Questions

Video

With doctors unable to prescribe an effective treatment for patients with progressive multiple sclerosis, an unanswered question has lingered for many years. A potential answer to this difficult question could be closer to reality than ever before.

With doctors unable to prescribe an effective treatment for patients with progressive multiple sclerosis, an unanswered question has lingered for many years. A potential answer to this difficult question could be closer to reality than ever before.

Stephen L. Hauser, MD, who chairs the neurology departmen at the University of California San Francisco School of Medicine discussed this potential new treatment during the ACTRIMS conference in New Orleans. While not yet approved by the US Food and Drug Administration Hauser said even the potential treatment was an exciting step forward in the field.

Related Videos
Addressing HS Risks at the Genetic Level, with Kai Li, BSc
Maternal Hidradenitits Suppurativa Linked to Neonatal Mortality, Pediatric Hospitalization Risk
Reviewing 2023 with FDA Commissioner Robert M. Califf, MD
A Year of RSV Highs and Lows, with Tina Tan, MD
Gestational Low-Dose Aspirin Does Not Increase Risk of IBD Flares in Women
Riha Bhatt, MD: Mimickers and Concurrent Diseases in Pediatric IBD
Elizabeth Spencer, MD: Precision Medicine in Pediatric IBD
Anita Clayton, MD: Zuranolone for Postpartum Depression
Mikkael Sekeres, MD:
Lynn Malec, MD: FVIII Therapy Improves Levels in Pediatric Patients with Hemophilia A
© 2024 MJH Life Sciences

All rights reserved.